5. Elliott JM, Cross DB, Cederholm-Williams SA, White HD. Neutralizing antibodies to streptokinase four years after intravenous thrombolytic therapy. The American journal of cardiology, 1993;71 (8):640-645.
https://doi.org/10.1016/0002-9149(93)91003-Z
7. Wu X-C, Ye R, Duan Y, Wong S-L. Engineering of plasmin-resistant forms of streptokinase and their production in Bacillus subtilis: streptokinase with longer functional half-life. Applied and environmental microbiology, 1998;64 (3):824-829.
https://doi.org/10.1128/AEM.64.3.824-829.1998
8. Shi G-Y, Chang B-I, Su S-W, Young K-C, Wu D-H, Chang L-C, Tsai Y-S, Wu H-L. Preparation of a novel streptokinase mutant with improved stability. Thrombosis and haemostasis, 1998;79 (05):992-997.
https://doi.org/10.1055/s-0037-1615108
9. Bandehpour M, Sharifnia Z, Mohajeri N, Taherkhani M, Koochaki A, Yarian F, Seyyed N, Shirvani R, Pakzad P, Saadat H. Comparative study of the reactivity of natural and mutated streptokinase with total antistreptokinase antibodies in human sera. Blood coagulation & fibrinolysis, 2012;23 (8):734-738.
https://doi.org/10.1097/MBC.0b013e328358e87b
10. Ojalvo A, Torrens I, Seralena A, de la Fuente J. Recombinant streptokinase with reduced immunoreactivity. Thrombosis and Haemostasis: Fk Schattauer Verlag Gmbh Po Box 10 45 43, Lenzhalde 3, D-70040 Stuttgart …; 1999:260-261.
11. Akbar G, Zia M, Ahmad A, Arooj N, Nusrat S. Review on streptokinase with its antigenic determinants and perspectives to develop its recombinant enzyme with minimum immunogenicity. Journal of Innovative Sciences, 2020;6 (1):17-23.
https://doi.org/10.17582/journal.jis/2020/6.1.17.23
12. Alinodehi NN, Sadeh S, Nezamiha FK, Keramati M, Hasanzadeh M, Mianroodi RA. Evaluation of activity kinetic parameters of SK319cys, as a new cysteine variant of streptokinase: a comparative study. Current Pharmaceutical Biotechnology, 2019;20 (1):76-83.
https://doi.org/10.2174/1389201020666190208155808
13. Alinodehi NN, Behrooz H, Sabaei M, Nezamiha FK, Mianroodi RA. Multiple Mutations on α, β and γ Domains of Streptokinase Lead to the Generation of Highly Efficient Cysteine Analogues with Promising Features. Current Pharmaceutical Biotechnology, 2022.
14. Alinodehi NN, Behrooz H, Sabaei M, Nezamiha FK, Mianroodi RA. Multiple Mutations on α, β and γ Domains of Streptokinase Lead to the Generation of Highly Efficient Cysteine Analogues with Promising Features. Current Pharmaceutical Biotechnology, 2023;24 (10):1326-1334.
https://doi.org/10.2174/1389201024666221124151623
17. Leach JK, Patterson E, O'Rear E. Distributed intraclot thrombolysis: mechanism of accelerated thrombolysis with encapsulated plasminogen activators. Journal of Thrombosis and Haemostasis, 2004;2 (9):1548-1555.
https://doi.org/10.1111/j.1538-7836.2004.00884.x
19. Mukhametova L, Aisina R, Tyupa D, Medvedeva A, Gershkovich K. Properties of streptokinase incorporated into polyethylene glycol microcapsules. Russian Journal of Bioorganic Chemistry, 2013;39 (4):390-396.
https://doi.org/10.1134/S1068162013040134
20. Leach JK, Edgar A, Patterson E, Miao Y, Johnson AE. Accelerated thrombolysis in a rabbit model of carotid artery thrombosis with liposome-encapsulated and microencapsulated streptokinase. Thrombosis and haemostasis, 2003;90 (07):64-70.
https://doi.org/10.1055/s-0037-1613600
21. Baharifar H, Khoobi M, Bidgoli SA, Amani A. Preparation of PEG-grafted chitosan/streptokinase nanoparticles to improve biological half-life and reduce immunogenicity of the enzyme. International journal of biological macromolecules, 2020;143:181-189.
https://doi.org/10.1016/j.ijbiomac.2019.11.157
22. Aisina R, Mukhametova L, Tyupa D, Gershkovich K, Gulin D, Varfolomeev S. Streptokinase-polyethylene glycol conjugates with increased stability and reduced side effects. Russian Journal of Bioorganic Chemistry, 2014;40 (5):516-525.
https://doi.org/10.1134/S1068162014050021
23. Thummala A, Leach JK, Patterson E, O'Rear E. Effect of encapsulation on plasminogen activator delivery to the microcirculation and its implications for bleeding. Clinical Hemorheology and Microcirculation, 2016;63 (4):373-379.
https://doi.org/10.3233/CH-152030
24. Koide A, Suzuki S, Kobayashi S. Preparation of polyethylene glycol-modified streptokinase with disappearance of binding ability towards anti-serum and retention of activity. FEBS letters, 1982;143 (1):73-76.
https://doi.org/10.1016/0014-5793(82)80276-7
25. Rajagopalan S, Gonias SL, Pizzo SV. A nonantigenic covalent streptokinase-polyethylene glycol complex with plasminogen activator function. The Journal of clinical investigation, 1985;75 (2):413-419.
https://doi.org/10.1172/JCI111715
29. Shamsi M, Zahedi P. On-chip preparation of streptokinase entrapped in chitosan nanoparticles used in thrombolytic therapy potentially. Journal of pharmaceutical sciences, 2017;106 (12):3623-3630.
https://doi.org/10.1016/j.xphs.2017.08.001
30. Aisina R, Mukhametova L, Gershkovich K, Ivanova E, Zakharyan E, Karakhanov E. Properties of Bioconjugates of Streptokinase with Anionic Polyamidoamine Dendrimers of Various Generations. Russian Journal of Bioorganic Chemistry, 2018;44 (5):528-537.
https://doi.org/10.1134/S1068162018040027
31. Abyadeh M, Zarchi AAK, Faramarzi MA, Amani A. Evaluation of factors affecting size and size distribution of chitosan-electrosprayed nanoparticles. Avicenna Journal of Medical Biotechnology, 2017;9 (3):126.
32. Yaghoobi N, Majidi RF, ali Faramarzi M, Baharifar H, Amani A. Preparation, optimization and activity evaluation of PLGA/streptokinase nanoparticles using electrospray. Advanced Pharmaceutical Bulletin, 2017;7 (1):131.
https://doi.org/10.15171/apb.2017.017
33. Modaresi SMS, Ejtemaei Mehr S, Faramarzi MA, Esmaeilzadeh Gharehdaghi E, Azarnia M, Modarressi MH, Baharifar H, Vaez SJ, Amani A. Preparation and characterization of self-assembled chitosan nanoparticles for the sustained delivery of streptokinase: an in vivo study. Pharmaceutical Development and Technology, 2014;19 (5):593-597.
https://doi.org/10.3109/10837450.2013.813542
34. Baharifar H, Tavoosidana G, Karimi R, Bidgoli SA, Ghanbari H, Faramarzi MA, Amani A. Optimization of self-assembled chitosan/streptokinase nanoparticles and evaluation of their cytotoxicity and thrombolytic activity. Journal of Nanoscience and Nanotechnology, 2015;15 (12):10127-10133.
https://doi.org/10.1166/jnn.2015.11696
35. Hasanpour A, Esmaeili F, Hosseini H, Amani A. Use of mPEG-PLGA nanoparticles to improve bioactivity and hemocompatibility of streptokinase: In-vitro and in-vivo studies. Materials Science and Engineering: C, 2021;118:111427.
https://doi.org/10.1016/j.msec.2020.111427
36. Baharifar H, Amani A. Cytotoxicity of chitosan/streptokinase nanoparticles as a function of size: an artificial neural networks study. Nanomedicine: Nanotechnology, Biology and Medicine, 2016;12 (1):171-180.
https://doi.org/10.1016/j.nano.2015.09.002
37. Daraee H, Etemadi A, Kouhi M, Alimirzalu S, Akbarzadeh A. Application of liposomes in medicine and drug delivery. Artificial cells, nanomedicine, and biotechnology, 2016;44 (1):381-391.
https://doi.org/10.3109/21691401.2014.953633
38. Vaidya B, Nayak MK, Dash D, Agrawal GP, Vyas SP. Development and characterization of highly selective target-sensitive liposomes for the delivery of streptokinase: in vitro/in vivo studies. Drug Delivery, 2016;23 (3):791-797.
https://doi.org/10.3109/10717544.2014.916770
39. Vaidya B, Agrawal G, Vyas SP. Platelets directed liposomes for the delivery of streptokinase: development and characterization. European Journal of Pharmaceutical Sciences, 2011;44 (5):589-594.
https://doi.org/10.1016/j.ejps.2011.10.004
40. Vaidya B, Nayak MK, Dash D, Agrawal G, Vyas SP. Development and characterization of site specific target sensitive liposomes for the delivery of thrombolytic agents. International journal of pharmaceutics, 2011;403 (1-2):254-261.
https://doi.org/10.1016/j.ijpharm.2010.10.028
41. Igor A, Tatyana V, Irina L, Katsiaryna D, Vladimir A. Efficiency of targeted delivery of streptokinase based on fibrin-specific liposomes in the in vivo experiment. Drug Delivery and Translational Research, 2023;13 (3):811-821.
https://doi.org/10.1007/s13346-022-01242-2
42. Nguyen PD, O'rear E, Johnson AE, Patterson E, Whitsett TL, Bhakta R. Accelerated thrombolysis and reperfusion in a canine model of myocardial infarction by liposomal encapsulation of streptokinase. Circulation research, 1990;66 (3):875-878.
https://doi.org/10.1161/01.RES.66.3.875
43. Leach K, O Rear E, Miao Y, Johnson A, Patterson E. Thrombolysis in a rabbit stroke model using liposomal-encapsulated streptokinase. Proceedings of the Annual Biochemical Engineering Symposium; 1999:51-55.
44. Perkins W, Vaughan D, Plavin S, Daley W, Rauch J, Lee L, Janoff A. Streptokinase entrapment in interdigitation-fusion liposomes improves thrombolysis in an experimental rabbit model. Thrombosis and haemostasis, 1997;77 (06):1174-1178.
https://doi.org/10.1055/s-0038-1656133
45. Nguyen P, O'rear E, Johnson A, Lu R, Fung B. Thrombolysis using liposomal-encapsulated streptokinase: an in vitro study. Proceedings of the Society for Experimental Biology and Medicine, 1989;192 (3):261-269.
https://doi.org/10.3181/00379727-192-42995
46. Jin S-E, Kim I-S, Kim C-K. Comparative effects of PEG-containing liposomal formulations on in vivo pharmacokinetics of streptokinase. Archives of Pharmacal Research, 2015;38 (10):1822-1829.
https://doi.org/10.1007/s12272-015-0594-7
47. Adzerikho I, Vladimirskaya T, Lutsik I, Dubatouka K, Agabekov V, Branovitskaya E, Chernyavsky E, Lugovska N. Fibrinspecific liposomes as a potential method of delivery of the thrombolytic preparation streptokinase. Journal of Thrombosis and Thrombolysis, 2022;53 (2):313-320.
https://doi.org/10.1007/s11239-021-02614-0
48. Erdoğan S, Oezer AY, Volkan B, Caner B, Bilgili H. Thrombus localization by using streptokinase containing vesicular systems. Drug Delivery, 2006;13 (4):303-309.
https://doi.org/10.1080/10717540600559544
49. Holt B, Gupta AS. Streptokinase loading in liposomes for vascular targeted nanomedicine applications: encapsulation efficiency and effects of processing. Journal of Biomaterials applications, 2012;26 (5):509-527.
https://doi.org/10.1177/0885328210374778
50. Wang X, Inapagolla R, Kannan S, Lieh-Lai M, Kannan RM. Synthesis, characterization, and in vitro activity of dendrimer− Streptokinase conjugates. Bioconjugate chemistry, 2007;18 (3):791-799.
https://doi.org/10.1021/bc060322d
51. Nguyen HX, O'Rear EA. An in vitro thrombolysis study using a mixture of fast-acting and slower release microspheres. Pharmaceutical research, 2016;33 (7):1552-1563.
https://doi.org/10.1007/s11095-016-1897-1
52. Rassam H, Allameh A, Eidi A, Alebouyeh M, Doroud D. Streptokinase Loaded Solid Lipid Nanoparticles: Preparation and Charactrization. Archives of Pharmacy Practice, 2019;1:178.
53. Rassam H, Allameh A, Eidi A, Alebouyeh M, Doroud D. Novel Formulation for Recombinant Streptokinase by Solid Lipid Nanoparticle: A Light at the End of the Tunnel. Archives of Pharmacy Practice, 2020;1:149.
)